Item 1A. RISK FACTORS

There have been no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information about share repurchases made by the Company of its common stock during the quarter ended September 30, 2025:


Period	Total Number of Shares Purchased	Weighted Average Price Paid Per Share(1)		Total Number of Shares Purchased as Part of a Publicly Announced Program	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions)(2)
July 1, 2025 — July 31, 2025	1,234,052	$	52.67	1,234,052	$	1,135
August 1, 2025 — August 31, 2025	7,411,362	$	54.49	7,411,362	$	731
September 1, 2025 — September 30, 2025	547,000	$	56.95	547,000	$	700
Total	9,192,414			9,192,414

(1)Calculated excluding commissions.

(2)On October 22, 2024, our Board of Directors authorized increasing the remaining share repurchase amount of the share repurchase program from $195 million to $2.0 billion and extending its expiration date from November 3, 2025 to November 3, 2026. On April 22, 2025, our Board of Directors authorized increasing the remaining share repurchase amount from $1.10 billion to $2.0 billion. Subsequently, on October 21, 2025, our Board of Directors authorized increasing the remaining share repurchase amount of the share repurchase program to $2.0 billion and extending its expiration date from November 3, 2026 to November 3, 2027.

All repurchases under the stock repurchase program are made from time to time at our discretion in accordance with applicable federal securities laws. All share repurchases of our common stock have been recorded as treasury stock.

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION